These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6061064)

  • 1. [Signs of tolerability in man, clinical pharmacology and activity of a new non-anticholinergic product active in gastroduodenitis and gastroduodenal ulcer (Milid)].
    Casone A; Borellini D; Jezzi B
    Minerva Med; 1967 Oct; 58(86):3699-704. PubMed ID: 6061064
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological and clinical studies of a non-anticholinergic antisecretory product: Milid (xylamide, CR 242)].
    Mainoli S; Milvio C; Borellini D
    Minerva Med; 1967 Oct; 58(86):3708-12. PubMed ID: 6061066
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of some conditions of chronic gastroduodenitis and of gastroduodenal ulcer with a preparation, for intravenous or intramuscular injection or oral administration, derived from a carboxyl halicyclic acid].
    Abbona C; Gatto PL; Bezante GC
    Minerva Med; 1967 Oct; 58(86):3691-9. PubMed ID: 6061063
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical considerations on the therapeutic effect of a new non-anticholinergic antisecretory preparation: Milid (xylamide, CR 242)].
    Castelli CA; Locatelli L; Salvioni GF
    Minerva Med; 1967 Oct; 58(86):3704-8. PubMed ID: 6061065
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation, in gastritis and gastroduodenal ulcers of a new non-anticholinergic compound with protective and antisecretory activity].
    Fantino M; Roccia L
    Minerva Med; 1967 Oct; 58(86):3677-85. PubMed ID: 6061061
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antisecretory therapeutic activity of Milid (xylamide, CR 242) in the treatment of gastroduodenal ulcer].
    Giordano G; Comi L
    Minerva Med; 1967 Oct; 58(86):3688-91. PubMed ID: 6061062
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of "Sinulene" in gastroduddenal ulcer and in gastroduodenitis. Clinical experience].
    Siciliani M
    Minerva Chir; 1968 Aug; 23(15):810-4. PubMed ID: 5686717
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aluminium glycyrrhetate in the therapy of gastroduodenal peptic ulcer and of other gastroduodenal diseases].
    Fontana G; Faggioli F
    Minerva Med; 1969 Feb; 60(17):745-60. PubMed ID: 5776059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of gastro-duodenal ulcer, gastritis and gastroduodenitis with an antisecretory, non-anticholinergic drug (Milid)].
    Borellini D; Milvio C
    Minerva Med; 1969 Mar; 60(23):1053-6. PubMed ID: 5781332
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic activity in gastric and duodenal ulcers, gastritis and gastroduodenitis of an anti-secretory, non-anticholinergic drug].
    Bianchi PG; Saccabusi E
    Minerva Med; 1969 Mar; 60(23):1044-52. PubMed ID: 5781331
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controlled clinical evaluation of the therapeutic value of antacid-antiulcer preparation].
    Lattanzi A; De Liperi E
    Minerva Med; 1967 Oct; 58(87):3736-43. PubMed ID: 6075229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and experimental data on some secretory functional aspects of the stomach in patients with gastrointestinal diseases treated with a gel of aluminum or magnesium hydroxide in a colloidal suspension ("Maalox")].
    Abbona C; Gatto PL; Bezante GC
    Minerva Gastroenterol; 1969; 15(2):86-93. PubMed ID: 5815483
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trials in several centers of aluminium glycyrrhetate in the therapy of ulcer disease].
    Bassi M; Botti G; Cacciari C; Cavazzuti F; Fontana G; Gambigliani Zoccoli A; Jori GP; Ponari O; Preziosi P; Visioli O
    Minerva Med; 1969 Feb; 60(17):721-37. PubMed ID: 5776058
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trials of a pharmacological perparation in the therapy of ulcerous gastroduodenitis].
    Linati E
    Minerva Med; 1969 Mar; 60(23):1038-43. PubMed ID: 5781330
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gastroprotective activity of a new substance (xylamide, Milid) in gastric disorders secondary to administration of corticoids].
    Gobbi F
    Minerva Med; 1967 Oct; 58(86):3685-8. PubMed ID: 5183197
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trial of a new preparation with anti-acid and gastroprotective action].
    Faggioli F
    Minerva Med; 1971 Oct; 62(81):3913-23. PubMed ID: 5125848
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and radiographical study on the effects of the treatment of peptic ulcer with a new antacid-antiulcer agent].
    Piro E; Florio F; Tripodi R
    Clin Ter; 1970 May; 53(4):323-48. PubMed ID: 4394193
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results obtained with Dogmagel in the treatment of gastroduodenal ulcer and gastroduodenitis].
    Sánchez García-Moreno I
    Rev Esp Enferm Apar Dig; 1974 Dec; 44(7):743-6. PubMed ID: 4445556
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of Levadial in the treatment of ulcer disease].
    Campesato A
    Minerva Gastroenterol; 1975; 21(3):155-60. PubMed ID: 1103006
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial of a new antacid-antiulcer preparation].
    Betti M
    Minerva Med; 1967 Aug; 58(69):2927-34. PubMed ID: 4383470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.